Home
About
Publications Trends
Recent Publications
Expert Search
Archive
harsh chemicals
Which Chemicals are Known Carcinogens?
Several chemicals have been classified as
carcinogens
by organizations such as the International Agency for Research on Cancer (IARC) and the Environmental Protection Agency (EPA). Some of the most notorious examples include:
Benzene
Asbestos
Formaldehyde
Arsenic
Tobacco smoke
Frequently asked queries:
What are Harsh Chemicals?
How Do Harsh Chemicals Cause Cancer?
Which Chemicals are Known Carcinogens?
How Can One Reduce Exposure to Harsh Chemicals?
What Should One Do If Exposed to a Carcinogenic Chemical?
Are There Any Emerging Concerns?
What About Treatment Delays?
How is PRC1 Expression Altered in Cancer?
6. What are the Results of Previous Screenings and Tests?
Which Regions are Most Affected?
How can personal monitoring support cancer survivors?
How Can Patients Protect Their Own Privacy?
What are the Common Types of Communication Disorders in Cancer Patients?
How Can Cancer Patients Incorporate More Protein into Their Diet?
What is the importance of data backup in cancer research?
How Long Can a Person Live with Cancer Without Treatment?
How Does the Gates Foundation Approach Cancer?
What is the prognosis for bladder cancer patients?
What Role Do Nutritional Supplements Play in Cancer Care?
How Do Genetic Conditions Relate to Cancer?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Diagnostics
Cancer Genomics
Cancer Therapy
Chemotherapy
Essential Thrombocythemia
hepatocellular carcinoma
Lung Cancer
Molecular Biomarkers
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Skin Cancer
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
and strategies
antibodies
antibody conjugates
Aptamers
artificial intelligence
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
CALR Mutation
cancer
cancer diagnosis
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
cell-free RNA
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
circulating tumor cells
circulating tumor DNA
Clonal Expansion
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Cytoreductive Therapyexpansion
cytotoxic agents
Deep Learning
dermatology
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
drug delivery systems
early detection
epirubicin-cyclophosphamide
Essential Thrombocythemia
exosomes
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
healthcare accessibility
Hepatocellular carcinoma
High Tumor
image processing
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
JAK2 Mutation
Keratinocyte
Lipid-based nanoparticles
Liquid Biopsies
Liquid biopsy
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
Megakaryocytes
metastasis
methyltransferase
minimal residual disease
mobile applications
Molecular Biomarkers
monoclonal antibodies
MPL Mutation
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Myeloproliferative Neoplasm
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
non-invasive diagnostics
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Personalized Treatment
Photobiomodulation therapy
Platelets
Polymeric nanoparticles
portal vein tumor thrombus
precision medicine
Precision Oncology
Predictive Biomarkers
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Resistance Mechanisms
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
Skin cancer screening
stereotactic body radiation therapy
targeted cancer therapy
Targeted Therapies
Targeted therapy
telemedicine
Thrombosis
Tolerability
transarterial chemoembolization
Tuberculosis
tumor biomarkers
tumor microenvironment
tumor progression
Tumor-Agnostic Treatments
user empowerment
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe